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Introduction {#sec001}
============

Recurrent tonsillitis is a childhood disease that involves the parenchyma of the palatine tonsils. The definition of recurrent disease may vary, but the criteria used at present are the development of 5 or more episodes of true tonsillitis per year, symptoms recurring for at least a year, and episodes that are disabling and that prevent normal functioning \[[@pone.0178115.ref001]\].

Most of the upper respiratory tract diseases in childhood tend to improve with time, although recurrent tonsillitis does not resolve spontaneously and requires treatment, with the highest risk of presentation in patients younger than 15 years. Options available for the treatment of recurrent disease are surgical and medical care with equal outcomes \[[@pone.0178115.ref002]\].

Recurrent tonsillitis has been linked to a wide variety of infectious agents \[[@pone.0178115.ref003]\], with the most common being *Streptococcus pyogenes*, followed by *Staphylococcus aureus* and *Haemophilus influenzae* \[[@pone.0178115.ref004]--[@pone.0178115.ref006]\].

In the development of recurrent tonsillitis, the bacterial factor plays an important role, but it may not be the only one, because certain genetic backgrounds may be related to stronger inflammation. Genetic variants of cytokines may alter the inflammatory response, and several genes encoding pro-inflammatory cytokines.

Among the well-studied single-nucleotide polymorphisms (SNPs) that may affect the inflammatory response is *TNFA-308G/A* (rs1800629), with guanine (G) as the common variant and adenine (A) as the less common one. The *TNFA--308A* allele shows a 6-to-7-fold higher gene transcription as compared to the common G allele \[[@pone.0178115.ref007], [@pone.0178115.ref008]\].

Furthermore, the --*31C/T* SNP (rs1143627) in the promoter of the *IL1B* gene has been associated with stronger inflammation in multiple populations, including the Mexican \[[@pone.0178115.ref009]--[@pone.0178115.ref011]\].

Genetic polymorphisms have been reported as risk factors for the development of recurrent tonsillitis, but the evidence is not strong enough \[[@pone.0178115.ref001]\]. For example, a case-control study indicated that parental atopy and a parental history of tonsillectomy would predict subsequent tonsillitis in their children \[[@pone.0178115.ref012]\].

The aim of the present study was to estimate the relative contribution of immunogenetic and microbiological factors in the development of recurrent tonsillitis in a Mexican population.

Methods {#sec002}
=======

Study population {#sec003}
----------------

We included 138 unrelated patients with clinically confirmed recurrent tonsillitis and an indication of tonsillectomy according to American Academy of Otolaryngology--Head and Neck Surgery \[[@pone.0178115.ref013], [@pone.0178115.ref014]\] (mean age, 6.05 years ± SD, 3.00; median age, 5 years, Female: 58: age range: 1--15 years). We also investigated 195 healthy subjects with no clinical history of recurrent tonsillitis (mean age = 28.18 years ± SD, 10.26, Female: 91; median age = 23 years, age range: 18--68 years) as controls. All controls were older than 18 years to minimize the risk of recurrent tonsillitis. The recruitment time was from April, 2015 to April, 2016.

Patients were enrolled from August, 2014 to May, 2015 at two hospitals from Nuevo Leon, Mexico. This study was performed with the approval of the Local Ethics Committee of both hospitals: Hospital Universitario "Dr. José Eleuterio González", Universidad Autónoma de Nuevo León (Approval OTI-007) and Hospital Materno Infantil de Alta Especialidad, Secretaria de Salud de Nuevo Leon (Approval 062/2014). Written informed consent was obtained from all subjects and patients. When applied, written informed consent was obtained from caretakers, or guardians on behalf of the minors enrolled in this study.

Microbiological examinations and semi-quantification of biofilm {#sec004}
---------------------------------------------------------------

From all control subjects, a tonsil swab culture was obtained for microbiological evaluation. From patients with recurrent tonsillitis, extracted tonsils (partially macerated) and tonsil swabs were cultured by standard methods.

Biofilm production by *S*. *aureus* and *H*. *influenzae* isolates was semi-quantified spectrophotometrically at an optical density of 595 nm (OD~595~: OD~595~ \< 0.12, non-biofilm producers; 0.13\<OD~595~ \< 0.24, weak biofilm producers; and OD~595~ \> 0.25, strong biofilm producers) after crystal violet staining according to methods previously reported either for *S*. *aureus* \[[@pone.0178115.ref015]\] or for *H*. *influenzae* \[[@pone.0178115.ref016], [@pone.0178115.ref017]\]. Control strains were *S*. *aureus* (ATCC 29213; strong biofilm producer), *Escherichia coli (*ATCC 25922, weak biofilm producer), and *Staphylococcus hominis* (ATCC 27844; no biofilm producer). All isolates were tested in quadruplicate in two different experiments carried out on different days.

Genotyping {#sec005}
----------

Genomic DNA was extracted from peripheral blood from both control and subjects by the phenol-chloroform-isoamyl alcohol method and precipitated with ethanol.

The *IL1B -31T/C* SNP (rs1143627) was evaluated by restriction fragment length polymorphism (PCR-RFLP) and the *TNFA-308G/A* SNP (rs1800629) by pyrosequencing as previously described \[[@pone.0178115.ref018]\].

Statistical analysis {#sec006}
--------------------

The Hardy-Weinberg equilibrium of alleles was assessed with a chi-square test. Statistically significant differences were determined by 2-tailed Student\'s *t*, chi-square, or Fisher's exact tests. A *P* value of \< 0.05 was considered significant. Odds ratio (OR) and corresponding 95% confidence interval (95% CIs) were computed using SPSS Statistics software version 20.0 (IMB Corporation). The dominant model of inheritance was used for analysis.

Results {#sec007}
=======

Microbiological results {#sec008}
-----------------------

Normal microbiota, but no potential pathogens, grew in cultures from control samples.

Considering cultures from both swab and extracted tonsil samples, *S*. *aureus* and *H*. *influenzae* were found more frequently in patients with recurrent tonsillitis than in control subjects (*P*\<0.0001). Cultures from extracted tonsils presented a higher diversity and quantity of potential pathogens; the most frequently detected pathogens were *S*. *aureus* (67/138; 48.6%), *H*. *influenzae* (44/138; 31.9%) and *S*. *pyogenes* 21/138 (15.2%) ([Table 1](#pone.0178115.t001){ref-type="table"}).

10.1371/journal.pone.0178115.t001

###### Microbiological evaluation from extracted tonsils and swab tonsils from all cases.

![](pone.0178115.t001){#pone.0178115.t001g}

  No. of microorganisms isolated        Tonsils swab n = 138 n(%) [\*](#t001fn001){ref-type="table-fn"}   Extracted tonsils n = 138 n(%)
  ------------------------------------- ----------------------------------------------------------------- --------------------------------
  1                                     65 (47.1)                                                         71 (51.4)
  2                                     26 (18.8)                                                         36 (26.1)
  3                                     6 (4.3)                                                           11 (8.0)
  **Microorganism isolated**                                                                              
  *Staphylococcus aureus*               53 (38.4)                                                         67 (48.6)
  *Haemophilus influenzae*              30 (21.7)                                                         44 (31.9)
  *Streptococcus pyogenes*              15 (10.9)                                                         21 (15.2)
  *Pseudomonas aeruginosa*              10 (7.2)                                                          10 (7.2)
  *Enterobacter cloacae*                4 (2.9)                                                           5 (3.6)
  *Streptococcus agalactiae*            2 (1.4)                                                           5 (3.6)
  *Citrobacter freundii*                6 (4.3)                                                           4 (2.9)
  *Klebsiella pneumoniae*               4 (2.9)                                                           4 (2.9)
  Group G β-hemolytic *Streptococcus*   3 (2.2)                                                           4 (2.9)
  *Streptococcus pneumoniae*            1 (0.7)                                                           3 (2.2)
  *Candida* spp.                        2 (1.4)                                                           2 (1.4)
  *Klebsiella oxytoca*                  2 (1.4)                                                           1 (0.7)
  *Pantoea agglomerans*                 2 (1.4)                                                           1 (0.7)
  *Burkholderia cepacia*                1 (0.7)                                                           1 (0.7)
  *Acinetobacter baumannii*             0 (0)                                                             1 (0.7)
  *Serratia plymuthica*                 0 (0)                                                             1 (0.7)
  *Pseudomonas pseudoalcaligenes*       0 (0)                                                             1 (0.7)
  *Chryseobacterium indologenes*        0 (0)                                                             1 (0.7)

\* All control subjects (n = 195) exhibited normal microbiota in the tonsils swab samples. Extracted tonsils were analyzed only in case patients.

We randomly selected 54 *S*. *aureus* isolates for biofilm evaluation and detected that 41/54 (75.9%) were biofilm producers (18 weak and 23 strong). Among *H*. *influenzae* isolates, 25 isolates were randomly selected for biofilm evaluation and 17/25 (68%) were biofilm producers (10 weak and 7 strong biofilm producers).

Allelic and genotypic associations {#sec009}
----------------------------------

The distribution of alleles and genotypes is shown in [Table 2](#pone.0178115.t002){ref-type="table"}. The genotype frequencies were in Hardy-Weinberg equilibrium for all loci studied. Patients with at least one copy of the *IL1B-31\*C* allele had a higher risk of recurrent tonsillitis (OR = 4.03; 95% CI = 1.27--14.27; *P* = 0.013). There were no significant differences for the *TNFA-308* locus.

10.1371/journal.pone.0178115.t002

###### Genotype and allele frequencies of *TNFA-308G/A* and *IL1B-31C/T* in recurrent tonsillitis and control patients.

![](pone.0178115.t002){#pone.0178115.t002g}

                       Genotype frequency n (%)   Allele frequency   Odds ratio (95% CI)   *P*                                  
  -------------------- -------------------------- ------------------ --------------------- ------- ------- -------------------- -------
  ***IL1B-31C/T***     CC                         CT                 TT                    **C**   **T**                        
  Cases (n = 138)      56 (40.6)                  78 (56.5)          4 (2.9)               0.69    0.31    4.03 (1.27--14.27)   0.013
  Controls (n = 195)   81 (42.6)                  93 (48.9)          21 (11.1)             0.65    0.35                         
  ***TNFA-308G/A***    AA                         GA                 GG                    **A**   **G**                        
  Cases (n = 138)      0 (0.0)                    21(15.2)           117 (84.8)            0.08    0.92                         NS
  Controls (n = 195)   2 (1.1)                    54 (28.4)          139 (73.2)            0.15    0.85                         

NS: not significant.

Considering *IL1B-31\*C* mutant allele in the control group, the power of our analysis (α = 0.05) was 0. 0.9853 in 138 cases and 195 controls.

When we considered the presence of *IL1B-31\*C* plus *S*. *aureus; IL1B-31\*C* plus *S*. *aureus* biofilm producer; *IL1B-31\*C* plus *H*. *influenzae IL1B-31\*C* plus *H*. *influenzae* biofilm producer, the OR tended to infinite ([Table 3](#pone.0178115.t003){ref-type="table"}).

10.1371/journal.pone.0178115.t003

###### Odds ratios (OR) with 95% confidence intervals (CIs) for risk factors.

![](pone.0178115.t003){#pone.0178115.t003g}

  ------------------------------------------------------------------------------------------------------------------------------------------------------------
                       *IL1B-31 \*C*              *IL1B-31 \*C* +\   *IL1B-31 \*C* +\                 *IL1B-31\*C* +\     *IL1B-31 \*C* +\
                                                  *S*. *aureus*      *S*. *aureus* biofilm producer   *H*. *influenzae*   *H*. *influenzae* biofilm producer
  -------------------- -------------------------- ------------------ -------------------------------- ------------------- ------------------------------------
  Cases (n = 138)      134                        67/134             38/52                            34/134              15/25

  Controls (n = 195)   174                        0/174              0                                0                   0

  OR (95%CI), *P*      4.03(1.27--14.27), 0.013   ∞ (39.21-∞), 0.0   ∞(14.436-∞), 0.0                 ∞ (12.387-∞), 0.0   ∞ (4.46-∞), 0.0
  ------------------------------------------------------------------------------------------------------------------------------------------------------------

Discussion {#sec010}
==========

In this study, we aimed to analyze the immunogenetic and microbiological contributions to the development of recurrent tonsillitis. Though cultures from either a swab or extracted tonsil sample from the same patient were consistent in about 60% of the cases, in the remaining 40% the cultures from extracted tonsils tended to have higher yields, both in number and species diversity, including pathogenic species.

Intracellular *S*. *aureus* has been reported as the most common cause of recurrent tonsillitis, and it has been suggested that *S*. *aureus* uses the intracellular location to survive the effects of antibiotics and the host immune response \[[@pone.0178115.ref019]\], which could explain the discrepancy between extracted tonsil and swab cultures in some cases, as infected cells at deeper tissue layers would be missed in swab cultures of superficial cells. Interestingly, cultures from control samples were limited to normal microbiota and no potential pathogen was detected, which could be explained by the inclusion criteria of the control group: 1) the absence of recurrent tonsillitis in their medical history and 2) their age; over 18 years is beyond the risk period of recurrent tonsillitis). Additionally, the sampling method was limited to superficial cells only which does not rule out that the control subjects could have any of the potential intracellular pathogens or crypt depth that could not be detected by the superficial culture of tonsils. Of course, ethical considerations do not impair the biopsy of the controls.

In our study cases were all from pediatrics patients (median age, 5 years) while controls were \> 18 years (median age, 28 years).We included older controls to minimize the immunogenetic risk for future recurrent tonsillitis. In case-control studies, the only variables should be the ones under study and differential work-up between control and case groups should be avoided. However, due to ethical reasons, biopsies were not obtained from controls. Culture from extracted tonsil facilitated the detection of more bacterial species, including potentially pathogenic ones. If we considered only the swab results when comparing patients with controls, the percentages of potential pathogens detected are lower, but equally significant. Overall, the most frequent pathogenic species were *S*. *aureus* and *H*. *influenzae*, which is consistent with the literature \[[@pone.0178115.ref019], [@pone.0178115.ref020]\].

The impact of biofilm formation has been previously reported in a case-control study that included 20 patients with recurrent tonsillitis and another 20 with no history of tonsillitis in the previous 2 years. Biofilm prevalence, analyzed by scanning electron microscopy, was significantly more prevalent in the recurrent tonsillitis group than in the control group \[[@pone.0178115.ref021]\]. Similarly, another study, in which *H*. *influenzae* was the most frequent pathogen in adenotonsillitis patients, proposed that biofilms could have an aetiopathogenetic role in chronic inflammatory mucosal reactions \[[@pone.0178115.ref020]\]. In this scenario, the presence of *H*. *influenzae* and *S*. *aureus*, especially in biofilms, may have a role in the development of the tonsillar inflammatory disease and an inadequate pro-inflammatory genetic background may increase this role.

The genetically regulated immune response seems to play a crucial role in determining the intensity of damage to the tonsils \[[@pone.0178115.ref022]\]. We found an association between the presence of the IL1B-31\*C allele (both homozygote plus heterozygote) and the development of recurrent tonsillitis. When we added the bacterial factor (*S*. *aureus* and *H*. *influenza*e) plus the production of biofilm, the OR increased to infinite.

Given these results, we hypothesize that a genetically conditioned inflammatory response (by the presence of IL1B-31\*C allele) and the infection with *S*. *aureus* and/or *H*. *influenzae* may lead to recurrent tonsillitis. To our knowledge, so far no other study has shown this association.

One of the few studies that have analyzed the genetic immune response and the development of recurrent tonsillitis showed that the presence of the Tool-Like receptor (TLR) 4-T399I polymorphism was associated with a 2-fold decreased risk of *H*. *influenzae* carriage (OR = 0.38, 95% CI = 0.15 to 0.96, P = 0.038); underlying that the host immune genetic variations might play a significant role in the susceptibility to common infections and tonsillar diseases \[[@pone.0178115.ref023]\]. The main limitation of this study is that we included only culture for aerobic bacterial species and no anaerobic culture was performed; and some anaerobic species may play a significant role in recurrent tonsillitis.

In conclusion, our results suggest that the presence of *IL1B -31\*C* allele may be a tonsillitis-enhancing factor, especially when species such as *S*. *aureus* or *H*. *influenzae* are present. If this effect is confirmed in populations other than the Mexican one, it may be used to detect patients at higher risk for recurrent tonsillitis.
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